NCT06532708 Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
| NCT ID | NCT06532708 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Tennessee |
| Condition | Opioid Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2024-07-12 |
| Primary Completion | 2024-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2024-07-12 with a primary completion date of 2024-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare opioid prescribing practices by either routine provider prescribing practices, or with the use of a calculator, i.e., the Opioid Calculator, published by the University of Michigan (www.opioidcalculator.org), with the intent of decreasing the number of pills.
Eligibility Criteria
Inclusion Criteria: * Women aged 18 to 80 * Undergoing planned laparoscopic hysterectomy as a day surgery procedure Exclusion Criteria: * Women aged 18 to 80 * Undergoing a non-laparoscopic unplanned surgical procedure * Patients with a history of opioid use disorder or current opioid use disorder
Frequently Asked Questions
Who can join the NCT06532708 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 80 Years, studying Opioid Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06532708 currently recruiting?
Yes, NCT06532708 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Tennessee to inquire about joining.
Where is the NCT06532708 trial being conducted?
This trial is being conducted at Memphis, United States.
Who is sponsoring the NCT06532708 clinical trial?
NCT06532708 is sponsored by University of Tennessee. The trial plans to enroll 12 participants.